In the last trading session, 5.77 million shares of the Scilex Holding Company (NASDAQ:SCLX) were traded, and its beta was 1.16. Most recently the company’s share price was $0.29, and it changed around $0.05 or 23.47% from the last close, which brings the market valuation of the company to $70.90M. SCLX currently trades at a discount to its 52-week high of $2.63, offering almost -806.9% off that amount. The share price’s 52-week low was $0.21, which indicates that the current value has risen by an impressive 27.59% since then.
Scilex Holding Company stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended SCLX as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. Scilex Holding Company is expected to report earnings per share of -0.09 for the current quarter.
Scilex Holding Company (NASDAQ:SCLX) trade information
Instantly SCLX has showed a green trend with a performance of 23.47% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.3100 on recent trading dayincreased the stock’s daily price by 6.45%. The company’s shares are currently down -31.66% year-to-date, but still down -7.81% over the last five days. On the other hand, Scilex Holding Company (NASDAQ:SCLX) is -33.77% down in the 30-day period.
Scilex Holding Company (SCLX) estimates and forecasts
The year-over-year growth rate is expected to be 21.75%, up from the previous year.
Consensus estimates provided by 2 financial analysts predict the company will bring in an average of 15.31M in revenue for the current quarter. 4 analysts expect Scilex Holding Company to make 25.88M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 13.46M and 10.88M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 13.72%. Forecasts for the next quarter put sales growth at 137.75%.
SCLX Dividends
Scilex Holding Company’s next quarterly earnings report is expected to be released in April.
SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF and Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 5.94 shares worth $1.73 million, making up 2.44% of all outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held roughly 3.71 shares worth around $1.08 million, which represents about 1.53% of the total shares outstanding.
